New hope for teens with chronic Graft-Versus-Host disease: belumosudil under study
NCT ID NCT06616415
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the drug belumosudil in Chinese teenagers aged 12 to 18 with chronic graft-versus-host disease (cGVHD), a complication after stem cell transplant. The goal was to see how well the drug works and how safe it is for those who didn't respond to steroids. Six participants took a tablet once daily, and researchers measured drug levels, response rates, and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- belumosudil (a drug taken as a tablet to treat chronic graft-versus-host disease)
- What this could lead to
- If it works, this could offer a new treatment option for teenagers with chronic graft-versus-host disease who haven't improved with steroids.
- What could go wrong
- This is a very small study (only 6 participants) and is already completed, so results may not apply to all patients. The drug may not work better than existing treatments or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational Site Number : 1560001
Beijing, 100045, China
-
Investigational Site Number : 1560002
Shanghai, 200127, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can meditation tame the Long-Term side effects of a stem cell transplant?
- Could a liquid form of a Graft-Versus-Host disease drug be as effective as the pill?
- Scientists map immune battlefield in chronic GVHD tissue
- Could a rheumatoid arthritis drug tame chronic GVHD and cut steroid use?
- Could an arthritis drug tame a tough transplant complication?
- Herbal extract shows promise for stiff skin and joints in transplant survivors